|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-2-1
|
|
pubmed:abstractText |
D(2) receptor function can be assessed by growth hormone (GH) response to apomorphine. Several association studies between dopamine receptor polymorphisms and results of the apomorphine challenge test with normal and alcohol-dependent subjects yielded inconsistent results. In this pilot study, we tested polymorphisms from the DRD2 region for GH response to apomorphine challenge in more detail.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ANKK1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Amphetamine,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD56,
http://linkedlifedata.com/resource/pubmed/chemical/Central Nervous System Stimulants,
http://linkedlifedata.com/resource/pubmed/chemical/DRD3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/NCAM1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Neural Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D3
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1878-4216
|
|
pubmed:author |
pubmed-author:Bie?kowskiPrzemys?awP,
pubmed-author:BrzuchalskiBogus?awB,
pubmed-author:GeisslerIngridI,
pubmed-author:GrabeHans JoergenHJ,
pubmed-author:GrzywaczAnnaA,
pubmed-author:JasiewiczAndrzejA,
pubmed-author:LuchtMichaelM,
pubmed-author:RimmbachChristianC,
pubmed-author:RosskopfDieterD,
pubmed-author:SamochowiecAgnieszkaA,
pubmed-author:SamochowiecJerzyJ,
pubmed-author:TyburaPiotrP,
pubmed-author:WysieckaJustyna Pe?kaJP
|
|
pubmed:copyrightInfo |
Copyright 2009 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
45-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19796663-Adult,
pubmed-meshheading:19796663-Alcoholism,
pubmed-meshheading:19796663-Amphetamine,
pubmed-meshheading:19796663-Analysis of Variance,
pubmed-meshheading:19796663-Antigens, CD56,
pubmed-meshheading:19796663-Area Under Curve,
pubmed-meshheading:19796663-Central Nervous System Stimulants,
pubmed-meshheading:19796663-Female,
pubmed-meshheading:19796663-Genome-Wide Association Study,
pubmed-meshheading:19796663-Genotype,
pubmed-meshheading:19796663-Growth Hormone,
pubmed-meshheading:19796663-Humans,
pubmed-meshheading:19796663-Male,
pubmed-meshheading:19796663-Middle Aged,
pubmed-meshheading:19796663-Neural Cell Adhesion Molecules,
pubmed-meshheading:19796663-Polymorphism, Single Nucleotide,
pubmed-meshheading:19796663-Protein-Serine-Threonine Kinases,
pubmed-meshheading:19796663-Receptors, Dopamine D3,
pubmed-meshheading:19796663-Time Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients.
|
|
pubmed:affiliation |
Hospital for Psychiatry and Psychotherapy, Ernst Moritz Arndt University Greifswald, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
